Rasha Kelej Recognized for 4th Year Most Influential African Woman and Everyday Hero 2022 for Her Efforts as a Health and Girl Education Champion

DUBAI, United Arab Emirates–(BUSINESS WIRE)–#AfricanFirstLadies—Senator, Dr. Rasha Kelej, CEO of Merck Foundation has been recognized, for…

Japan National Tourism Organization Promotes Japan as a Gastronomy Tourism Destination

Participated in the 7th UNWTO World Forum on Gastronomy Tourism held in Nara, Japan, attended by…

REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction of Acute GvHD from Phase 2b Study at the 2022 ASH Annual Meeting

RGI-2001 was well tolerated and associated with a meaningful reduction in the incidence of severe acute…

Deenova Celebrates a Year of Undisputed Growth With the Latest Award of Piacenza AUSL Public Tender

MILAN–(BUSINESS WIRE)–After successful market entries in Germany, UK and the 3 years of record breaking sales…

Battery Ventures Announces Sale of Physical-Security Technology Firm Qognify to Hexagon AB

Qognify provides video and enterprise incident-management solutions for improving physical security and business operations to companies…

ENHERTU® Approved in the EU for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer

First HER2 directed medicine to be approved for gastric cancer in the EU in more than…

ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer

Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival…

Mitsubishi Electric to Delist Shares on London Stock Exchange

TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has decided to apply for the delisting…

EnginZyme Raises €21 Million in Series B to Accelerate the Commercialisation of Its Cell-Free Biomanufacturing Technology

STOCKHOLM–(BUSINESS WIRE)–EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products,…

Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology

Sanofi gains exclusive license to Innate’s B7H3 ANKETTM program and options for two additional targets; Upon…